Abstract
We investigated the role of NAT2 on clonazepam acetylation, using transiently expressed human NAT2 alleles. The NAT25*B and the NAT2*6A variant alleles cause a 20 and 22-fold reduction in the Vmax, respectively. We conclude that NAT2 is responsible for 7-aminoclonazepam acetylation and that NAT2 gene polymorphisms impair such metabolic pathway.
Keywords: NAT2, acetylation, polymorphism, pharmacogenomics
Drug Metabolism Letters
Title: Effect of Common NAT2 Variant Alleles in the Acetylation of the Major Clonazepam Metabolite, 7-minoclonazepam
Volume: 1 Issue: 1
Author(s): M. Olivera, C. Martinez, G. Gervasini, J. A. Carrillo, S. Ramos, J. Benitez, E. Garcia-Martin and J. A. G. Agundez
Affiliation:
Keywords: NAT2, acetylation, polymorphism, pharmacogenomics
Abstract: We investigated the role of NAT2 on clonazepam acetylation, using transiently expressed human NAT2 alleles. The NAT25*B and the NAT2*6A variant alleles cause a 20 and 22-fold reduction in the Vmax, respectively. We conclude that NAT2 is responsible for 7-aminoclonazepam acetylation and that NAT2 gene polymorphisms impair such metabolic pathway.
Export Options
About this article
Cite this article as:
Olivera M., Martinez C., Gervasini G., Carrillo A. J., Ramos S., Benitez J., Garcia-Martin E. and G. Agundez A. J., Effect of Common NAT2 Variant Alleles in the Acetylation of the Major Clonazepam Metabolite, 7-minoclonazepam, Drug Metabolism Letters 2007; 1 (1) . https://dx.doi.org/10.2174/187231207779814283
DOI https://dx.doi.org/10.2174/187231207779814283 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
Related Articles
-
Statins in Bacteremia, Sepsis and Pneumonia: Have We Found the Holy Grail?
Recent Patents on Inflammation & Allergy Drug Discovery Severe Hypoglycemia Due to Possible Interaction Between Glibenclamide and Sorafenib in a Patient with Hepatocellular Carcinoma
Current Drug Safety Essential Oil Chemical Composition of Vitex agnus-castus L. from Southern-West Algeria and Its Antimicrobial Activity
Current Bioactive Compounds Advances on Semisynthesis, Total Synthesis, and Structure-Activity Relationships of Honokiol and Magnolol Derivatives
Mini-Reviews in Medicinal Chemistry Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and COPD
Current Medicinal Chemistry White Matter Damage Along the Uncinate Fasciculus Contributes to Cognitive Decline in AD and DLB
Current Alzheimer Research Herbal Medicines for the Prevention and Treatment of Alzheimer's Disease
Current Pharmaceutical Design Inhibition of Amyloid Fibrillation by Small Molecules and Nanomaterials: Strategic Development of Pharmaceuticals Against Amyloidosis
Protein & Peptide Letters Statins And Stroke
Current Medicinal Chemistry Atherosclerotic Process in Seroreverter Children and Adolescents Exposed to Fetal Antiretroviral Therapy
Current HIV Research Finding Simple Rules for Discriminating Folding Rate Change upon Single Mutation by Statistical and Learning Methods
Protein & Peptide Letters Mitochondrial-Targeted Plastoquinone Derivatives. Effect on Senescence and Acute Age-Related Pathologies
Current Drug Targets Recent Updates of N-Type Calcium Channel Blockers with Therapeutic Potential for Neuropathic Pain and Stroke
Current Topics in Medicinal Chemistry Pathomechanisms of Myocardial Dysfunction in Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets D-Serine Regulation: A Possible Therapeutic Approach for Central Nervous Diseases and Chronic Pain
Mini-Reviews in Medicinal Chemistry Disease Progression in HIV Late Presenters: the Role of HIV Clinical Indicator Diseases Prior to HIV Diagnosis
Current HIV Research The Vitamin D Neuroendocrine System as a Target for Novel Neurotropic Drugs
CNS & Neurological Disorders - Drug Targets Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Stability of Drugs of Abuse in Urine Samples at Room Temperature by Use of a Salts Mixture
Current Pharmaceutical Biotechnology PUFA for Human Health: Diet or Supplementation?
Current Pharmaceutical Design